Preferences of women with epithelial ovarian cancer for aspects of genetic testing.
Brittany A DavidsonJessie EhrismanShelby D ReedJui-Chen YangAdam BuchananLaura J HavrileskyPublished in: Gynecologic oncology research and practice (2019)
Low out-of-pocket cost, high probability of detecting deleterious mutations and high probability of a VUS result are preferred by patients with EOC considering genetic testing.
Keyphrases